Masaryk Memorial Cancer Institute, Department of Comprehensive Cancer Care, Brno, Czech Republic.
J Cell Mol Med. 2011 Aug;15(8):1636-44. doi: 10.1111/j.1582-4934.2011.01317.x.
MicroRNAs (miRNAs) are endogenously expressed small non-coding RNAs that act as post-transcriptional regulators of gene expression. Dysregulation of these molecules has been indicated in the development of many cancers. Altered expression levels of several miRNAs were identified also in glioblastoma. It was repeatedly found that miRNAs are involved in important signalling pathways, which play roles in crucial cellular processes, such as proliferation, apoptosis, cell cycle regulation, invasion, angiogenesis and stem cell behaviour. Therefore, miRNAs represent promising therapeutic targets in glioblastoma. In this review, we summarize the current knowledge about miRNAs significance in glioblastoma, with special focus on their involvement in core signalling pathways, their roles in drug resistance and potential clinical implications.
微小 RNA(miRNAs)是内源性表达的小非编码 RNA,作为基因表达的转录后调节剂。这些分子的失调已在许多癌症的发展中得到表明。在神经胶质瘤中也发现了几种 miRNAs 的表达水平改变。反复发现,miRNAs 参与重要的信号通路,这些通路在关键的细胞过程中发挥作用,如增殖、凋亡、细胞周期调节、侵袭、血管生成和干细胞行为。因此,miRNAs 是神经胶质瘤有前途的治疗靶点。在这篇综述中,我们总结了 miRNAs 在神经胶质瘤中的重要性的现有知识,特别关注它们在核心信号通路中的参与、它们在耐药性中的作用以及潜在的临床意义。